Literature DB >> 2189584

Diagnostic performance indices for immunofluorescent tests and enzyme immunoassays of leishmaniasis sera from northern and north-eastern Brazil.

M C Guimarães1, B J Celeste, E L Franco.   

Abstract

A total of 341 sera were screened for anti-Leishmania IgA, IgG, and IgM antibodies by immunofluorescent (IF) tests and enzyme immunoassay (ELISA). Altogether, 292 of the sera originated from patients with clinically as well as parasitologically diagnosed (positive lesion imprint or the Montenegro skin test) cutaneous leishmaniasis; 49 of the sera were from controls from the same base population. In terms of diagnostic performance, the ELISAs for IgG and IgM yielded indices of diagnostic utility, and the positive predictive value for the IgG-ELISA was 94.6%. A remarkably high specificity (100%) was obtained with the IgA-IF test, but its sensitivity was very low.

Entities:  

Mesh：

Year:  1990        PMID： 2189584      PMCID： PMC2393007     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  7 in total

1.  Subcellular and taxonomic specificity of monoclonal antibodies to New World Leishmania.

Authors:  R L Anthony; K M Williams; J B Sacci; D C Rubin
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

2.  Rheumatoid factors as a cause for false positive IgM anti-toxoplasma fluorescent tests. A technique for specific results.

Authors:  M E Camargo; P G Leser; A Rocca
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1972 Sep-Oct       Impact factor: 1.846

3.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

4.  Leishmaniasis in Brazil. XIV. Leishmanial and trypanosomal IgA antibody in patients with leishmaniasis and Chagas's disease.

Authors:  J J Shaw; R Lainson
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

5.  Parasitologic and immunologic diagnosis of American (mucocutaneous) leishmaniasis.

Authors:  C A Cuba Cuba; P D Marsden; A C Barreto; R Rocha; R R Sampaio; L Patzlaff
Journal:  Bull Pan Am Health Organ       Date:  1981

6.  Biochemical identification of the leishmanias.

Authors:  M A Miles
Journal:  Bull Pan Am Health Organ       Date:  1985

7.  Micro enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of New World leishmaniasis.

Authors:  R L Anthony; H A Christensen; C M Johnson
Journal:  Am J Trop Med Hyg       Date:  1980-03       Impact factor: 2.345
  7 in total
  8 in total

1.  Mucosal Leishmania infantum infection.

Authors:  Joachim Richter; Ingrid Hanus; Dieter Häussinger; Thomas Löscher; Gundel Harms
Journal:  Parasitol Res       Date:  2011-04-16       Impact factor: 2.289

2.  Recombinant Leishmania Hsp90 and Hsp70 are recognized by sera from visceral leishmaniasis patients but not Chagas' disease patients.

Authors:  C R de Andrade; L V Kirchhoff; J E Donelson; K Otsu
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis.

Authors:  F Tebourski; A el Gaied; H Louzir; R Ben Ismail; R Kammoun; K Dellagi
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  Recombinant Leishmania infantum heat shock protein 83 for the serodiagnosis of cutaneous, mucosal, and visceral leishmaniases.

Authors:  Beatriz Julieta Celeste; Maria Carmen Arroyo Sanchez; Eduardo Milton Ramos-Sanchez; Luiz Guilherme M Castro; Francisco Assis Lima Costa; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

5.  Use of Recombinant Antigens for Sensitive Serodiagnosis of American Tegumentary Leishmaniasis Caused by Different Leishmania Species.

Authors:  Camila Massae Sato; Maria Carmen Arroyo Sanchez; Beatriz Julieta Celeste; Malcolm S Duthie; Jeffrey Guderian; Steven G Reed; Maria Edileuza Felinto de Brito; Marliane Batista Campos; Helia Valeria de Souza Encarnação; Jorge Guerra; Tirza Gabrielle Ramos de Mesquita; Suzana Kanawati Pinheiro; Rajendranath Ramasawmy; Fernando Tobias Silveira; Marina de Assis Souza; Hiro Goto
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

6.  New antigens for the serological diagnosis of human visceral leishmaniasis identified by immunogenomic screening.

Authors:  Ana Maria Ravena Severino Carvalho; Tiago Antônio de Oliveira Mendes; Eduardo Antonio Ferraz Coelho; Mariana Costa Duarte; Daniel Menezes-Souza
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

7.  Evidence for Seroprevalence in Human Localized Cutaneous Leishmaniasis Caused by Leishmania donovani in Sri Lanka.

Authors:  Yamuna Deepani Siriwardana; Bhagya Deepachandi; Samantha Ranasinghe; Preethi Soysa; Nadira Karunaweera
Journal:  Biomed Res Int       Date:  2018-01-17       Impact factor: 3.411

Review 8.  Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum.

Authors:  Maude F Lévêque; Laurence Lachaud; Loïc Simon; Emilie Battery; Pierre Marty; Christelle Pomares
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.